Whole-transcriptome Gene Expression Profiling in an Epidermolysis Bullosa Simplex Dowling-Meara Model Keratinocyte Cell Line Uncovered Novel, Potential Therapeutic Targets and Affected Pathways
Overview
General Medicine
Authors
Affiliations
Background: To be able to develop effective therapeutics for epidermolysis bullosa simplex (EBS), it is necessary to elucidate the molecular pathomechanisms that give rise to the disease's characteristic severe skin-blistering phenotype.
Results: Starting with a whole-transcriptome microarray analysis of an EBS Dowling-Meara model cell line (KEB7), we identified 207 genes showing differential expression relative to control keratinocytes. A complementary qRT-PCR study of 156 candidates confirmed 76.58 % of the selected genes to be significantly up-regulated or down-regulated (p-value <0.05) within biological replicates. Our hit list contains previously identified genes involved in epithelial cell proliferation, cell-substrate adhesion, and responses to diverse biological stimuli. In addition, we identified novel candidate genes and potential affected pathways not previously considered as relevant to EBS pathology.
Conclusions: Our results broaden our understanding of the molecular processes dysregulated in EBS.
Bchetnia M, Powell J, McCuaig C, Boucher-Lafleur A, Morin C, Dupere A Int J Mol Sci. 2024; 25(17).
PMID: 39273442 PMC: 11394917. DOI: 10.3390/ijms25179495.
Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.
Evtushenko N, Beilin A, Kosykh A, Vorotelyak E, Gurskaya N Int J Mol Sci. 2021; 22(22).
PMID: 34830328 PMC: 8624175. DOI: 10.3390/ijms222212446.